Exact Mass: 307.25111580000004

Exact Mass Matches: 307.25111580000004

Found 33 metabolites which its exact mass value is equals to given mass value 307.25111580000004, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Pumiliotoxin A

Pumiliotoxin A

C19H33NO2 (307.25111580000004)


   

Fingolimod

2-amino-2-(2-(4-Octylphenyl)ethyl)-1,3-propanediol hydrochloride

C19H33NO2 (307.25111580000004)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Pumiliotoxin A

6-(6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

(R)-(-)-Dysidazirine

(R)-(-)-Dysidazirine

C19H33NO2 (307.25111580000004)


   

Fingolimod

Fingolimod

C19H33NO2 (307.25111580000004)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

C19H33NO2

C19H33NO2 (307.25111580000004)


   

2-hydroxy-2-methyl-N-{trans-1-methyl-4-[(2E,4E)-6-methylhepta-2,4-dien-2-yl]cyclohexyl}-propanamide

2-hydroxy-2-methyl-N-{trans-1-methyl-4-[(2E,4E)-6-methylhepta-2,4-dien-2-yl]cyclohexyl}-propanamide

C19H33NO2 (307.25111580000004)


   

octahydro-6-(4-hydroxy-2,5-dimethyl-5-octenylidene)-8-methyl-8-indolizinol

octahydro-6-(4-hydroxy-2,5-dimethyl-5-octenylidene)-8-methyl-8-indolizinol

C19H33NO2 (307.25111580000004)


   

cylindricine C

cylindricine C

C19H33NO2 (307.25111580000004)


   

3-O-Tetradecanoyl-1-cyano-2-methyl-1-propene

3-O-Tetradecanoyl-1-cyano-2-methyl-1-propene

C19H33NO2 (307.25111580000004)


   

(8S,Z)-6-((2R,E)-4-hydroxy-2,5-dimethyloct-5-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-4-hydroxy-2,5-dimethyloct-5-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

(2R)-1-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethyloctan-4-one

(2R)-1-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethyloctan-4-one

C19H33NO2 (307.25111580000004)


   

(7R)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloctan-3-one

(7R)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloctan-3-one

C19H33NO2 (307.25111580000004)


   

(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

(8S,Z)-6-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

(7R,8R,E)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

C19H33NO2 (307.25111580000004)


   

FTY720

2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, hydrochloride

C19H33NO2 (307.25111580000004)


   

R-Dysidazirine

methyl 3-(pentadec-1E-enyl)-2H-azirine-2S-carboxylate

C19H33NO2 (307.25111580000004)


   

N-(2,6-dicyclohexyloxan-4-yl)acetamide

N-(2,6-dicyclohexyloxan-4-yl)acetamide

C19H33NO2 (307.25111580000004)


   

1,7,7-trimethyl-N,N-bis(2-methylpropyl)-2-oxo-4-bicyclo[2.2.1]heptanecarboxamide

1,7,7-trimethyl-N,N-bis(2-methylpropyl)-2-oxo-4-bicyclo[2.2.1]heptanecarboxamide

C19H33NO2 (307.25111580000004)


   

Octahydro-6-(6-hydroxy-2,5-dimethyl-4-octen-1-ylidene)-8-methylindolizin-8-ol

Octahydro-6-(6-hydroxy-2,5-dimethyl-4-octen-1-ylidene)-8-methylindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

(6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol

(6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

methyl (2r)-3-[(1e)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

methyl (2r)-3-[(1e)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

C19H33NO2 (307.25111580000004)


   

methyl 3-(pentadec-1-en-1-yl)-2h-azirine-2-carboxylate

methyl 3-(pentadec-1-en-1-yl)-2h-azirine-2-carboxylate

C19H33NO2 (307.25111580000004)


   

3-o-tetradecanoyl-1-cyano-2-methyl-1-propene

NA

C19H33NO2 (307.25111580000004)


{"Ingredient_id": "HBIN009382","Ingredient_name": "3-o-tetradecanoyl-1-cyano-2-methyl-1-propene","Alias": "NA","Ingredient_formula": "C19H33NO2","Ingredient_Smile": "CCCCCCCCCCCCCC(=O)OCC(=CC#N)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21026","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(6z,8s)-6-[(4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s)-6-[(4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C19H33NO2 (307.25111580000004)


   

methyl 3-[(1z)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

methyl 3-[(1z)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

C19H33NO2 (307.25111580000004)


   

(6z,8s,8as)-6-[(2r,4z,6r)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s,8as)-6-[(2r,4z,6r)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

2-hydroxy-2-methyl-n-[(1r,4r)-1-methyl-4-[(2e,4e)-6-methylhepta-2,4-dien-2-yl]cyclohexyl]propanimidic acid

2-hydroxy-2-methyl-n-[(1r,4r)-1-methyl-4-[(2e,4e)-6-methylhepta-2,4-dien-2-yl]cyclohexyl]propanimidic acid

C19H33NO2 (307.25111580000004)


   

(3r,5s,7ar,11ar)-5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

(3r,5s,7ar,11ar)-5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C19H33NO2 (307.25111580000004)


   

(6z,8s,8as)-6-[(2r,4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s,8as)-6-[(2r,4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.25111580000004)


   

2-hydroxy-2-methyl-n-[1-methyl-4-(6-methylhepta-2,4-dien-2-yl)cyclohexyl]propanimidic acid

2-hydroxy-2-methyl-n-[1-methyl-4-(6-methylhepta-2,4-dien-2-yl)cyclohexyl]propanimidic acid

C19H33NO2 (307.25111580000004)